I want to know the answer to the following question:
What type of risk assessment results in approving the drug to go on the market?
All the background I'm provided with is that "The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted.". Is that enough to answer the question?